Indivior
Mark Doutt has a strong background in pharmaceutical sales, with experience in promoting various drugs to healthcare professionals. With a focus on rare diseases and pain management, Mark has consistently driven new business and maintained accounts. Known for effectively implementing sales strategies, Mark has a proven track record of achieving sales targets and boosting market share.
This person is not in any offices
Indivior
5 followers
Indivior is a specialty pharmaceuticals business. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.